Mike Williams of Genesis Asset Management and Douglas Roberts of ChannelCapitalResearch.com shared their investment strategies. (Part One)
Though Sonia Sotomayor is widely expected to win confirmation to the US Supreme Court, the business community is still wondering just what kind of justice she'll be
The Lightning Round is extended in this CNBC.com exclusive feature.
The S&P edged higher on Thursday with investors rotating into beaten down energy names and financials and out of consumer staples and pharma.
Stocks squeaked out another gain Thursday as investors were encouraged by Alcoa's beat and a drop in jobless claims but pharmaceutical and retail stocks dragged.
A late upturn pushed stocks higher Wednesday as investors rotated into defensive stocks like pharmaceuticals and Alcoa advanced ahead of earnings.
Stocks turned lower Wednesday as investors got defensive ahead of earnings season, rotating into pharmaceuticals and out of techs.
Perhaps reflecting concerns about the size and growth of the market for HPV shots and GSK's late entry, investors are not enthusiastic about the prestigious publication of the company's robust new test results. As I write this, GSK shares are the biggest percentage loser in big pharma.
Stocks ended mixed Monday as a dismal jobs report last week and expectations for a gloomy earnings season nagged at the market. But the Dow eked out a gain amid some bargain hunting.
Stocks rallied Monday as convicted Ponzi swindler Bernie Madoff received the maximum sentence and oil topped $71 a barrel. Plus, there was some window dressing as Tuesday marks the end of the second quarter.
President Obama is prescribing change in the healthcare system. The issue is front and center right now before Congress and Wall Street...We may see some volatility in a sector that’s traditionally very stable. Analysts say it’s time to reexamine your pharma stocks and position yourself for the changes President Obama will make.
Stocks losses approached 1 percent off the opening bell on Monday as summer apathy increased, threatening to snuff out the rally of the past three months. A June buyer's strike received more fuel after the World Bank cut its 2009 forecasts for most economies. Read and listen to what the experts had to say...
Philip Gotthelf, president and commodities analyst at Equidex and Nick Bennenbroek, head of currency strategy at Wells Fargo shared their best commodity and currency plays.
Stocks are weaker, the dollar is up, as the World Bank has cut its 2009 global growth forecast, saying the world economy will shrink 2.9 percent, worse than prior predictions of a decline of 1.7 percent, and noting that a retreat from emerging market investments will deepen poverty in less developed countries.
Cramer makes the call on viewers' favorite stocks.
Stocks logged their worst day in a month Monday as a key manufacturing gauge came in weaker than expected and the dollar made a comeback.
The Dow eked out a gain Friday, bumping it into positive territory for the year, as Bank of America shares rallied. But techs, energy and commodities retreated as crude oil dropped to around $72 a barrel.
Stocks opened lower Friday as crude oil dropped below $71 a barrel and banks dragged after Bank of America lowered its outlook for the sector.
Floor trading resumed at the New York Stock Exchange after a computer glitch knocked out trading in 242 stocks around midday.
Dr. Mark Monane, senior biotech analyst at Needham & Co., named some biotech stocks that look attractive.